BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Z, Cai Y, Yang C, Chen Z, Sun H, Xu Y, Chen W, Xu D, Tian W, Wang H. Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling. Onco Targets Ther 2018;11:6579-87. [PMID: 30323630 DOI: 10.2147/OTT.S174846] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Lu Y, Wang M, Wu Y, Wang X, Li Y. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. J Mol Med (Berl) 2021;99:193-212. [PMID: 33392633 DOI: 10.1007/s00109-020-02015-5] [Reference Citation Analysis]
2 Liu B, Zhang G, Cui S, Du G. Inhibition of RNF6 alleviates traumatic brain injury by suppressing STAT3 signaling in rats. Brain Behav 2020;10:e01847. [PMID: 32955171 DOI: 10.1002/brb3.1847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Gong Y, Jiao Y, Qi X, Fu J, Qian J, Zhu J, Yang H, Tang L. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02503-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhu K, Bai H, Mu M, Xue Y, Duan Z. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling. FEBS Open Bio 2021;11:2041-9. [PMID: 34081837 DOI: 10.1002/2211-5463.13216] [Reference Citation Analysis]
5 Chai Y, Jiao S, Peng X, Gan Q, Chen L, Hu X, Hao L, Zhang S, Tao Q. RING-Finger Protein 6 promotes Drug Resistance in Retinoblastoma via JAK2/STAT3 Signaling Pathway. Pathol Oncol Res 2022;28:1610273. [PMID: 35369571 DOI: 10.3389/pore.2022.1610273] [Reference Citation Analysis]
6 Zhang J, Wang Z, Zhang H, Dai Z, Liang X, Li S, Zhang X, Liu F, Liu Z, Yang K, Cheng Q. Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas. Front Cell Dev Biol 2022;9:754873. [DOI: 10.3389/fcell.2021.754873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ashrafizadeh M, Zarrabi A, Orouei S, Zarrin V, Rahmani Moghadam E, Zabolian A, Mohammadi S, Hushmandi K, Gharehaghajlou Y, Makvandi P, Najafi M, Mohammadinejad R. STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects. Biology (Basel) 2020;9:E126. [PMID: 32545648 DOI: 10.3390/biology9060126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
8 Shen C, Liu J, Wang J, Yang X, Niu H, Wang Y. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA. Dis Markers 2020;2020:4312629. [PMID: 32454905 DOI: 10.1155/2020/4312629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wang M, Dai W, Ke Z, Li Y. Functional roles of E3 ubiquitin ligases in gastric cancer. Oncol Lett 2020;20:22. [PMID: 32774495 DOI: 10.3892/ol.2020.11883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Liu Y, Chen P, Qi D, Chen L. Glaucocalyxin A Inhibits the Malignancies of Gastric Cancer Cells by Downregulating MDM2 and RNF6 via MiR-3658 and the SMG1-UPF mRNA Decay Pathway. Front Oncol 2022;12:871169. [DOI: 10.3389/fonc.2022.871169] [Reference Citation Analysis]
11 Zapolnik P, Pyrkosz A. RNF6 as an Oncogene and Potential Therapeutic Target—A Review. BioTech 2020;9:22. [DOI: 10.3390/biotech9040022] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]